Frances M Boyle (Fran Boyle, Frances Boyle)
Publication Activity (10 Years)
Years Active: 2016-2024
Publications (10 Years): 24
Publications (10 Years): 24
Publications
- Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D JohnstonAdjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
- Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D JohnstonAdjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
- Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D JohnstonAdjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
- Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D JohnstonAdjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
- Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D JohnstonAdjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
- Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D JohnstonAdjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
- Kathy L Flitcroft, Erin Mathieu, Meagan E Brennan, Kylie Snook, Julia Hoffman, Ian Campbell, Jenni Scarlet, Heather Flay, April Z H Wong, Frances M Boyle, Madeleine T King, Andrew J Spillane
- Julie Winstanley, Edward White, Robyn P M Saw, Teresa Young, Bryan Burmeister, Dejan Nikolic, Iria Busto-Cornide, Nicolás Iglesias-Pena, Frances M Boyle
- Byeongsang Oh, Albert Yeung, Penelope Klein, Linda Larkey, Carolyn Ee, Chris Zaslawski, Tish Knobf, Peter Payne, Elisabet Stener-Victorin, Richard Lee, Whanseok Choi, Mison Chun, Massimo Bonucci, Hanne-Doris Lang, Nick Pavlakis, Frances M Boyle, Stephen Clarke, Michael Back, Peiying Yang, Yulong Wei, Xin-Feng Guo, Chi-Hsiu D Weng, Michael R Irwin, Aymen A Elfiky, David Rosenthal
- Nicholas Zdenkowski, Phyllis N Butow, Elizabeth Hutchings, Charles D Douglas, Joseph R Coll, Frances M Boyle